nodes	percent_of_prediction	percent_of_DWPC	metapath
Saxagliptin—SLCO4C1—Methotrexate—muscle cancer	0.241	0.261	CbGbCtD
Saxagliptin—ABCC1—Dactinomycin—muscle cancer	0.175	0.19	CbGbCtD
Saxagliptin—ABCC1—Vincristine—muscle cancer	0.108	0.117	CbGbCtD
Saxagliptin—ABCC1—Etoposide—muscle cancer	0.0989	0.107	CbGbCtD
Saxagliptin—ABCC1—Doxorubicin—muscle cancer	0.0674	0.0731	CbGbCtD
Saxagliptin—ABCC1—Methotrexate—muscle cancer	0.0653	0.0708	CbGbCtD
Saxagliptin—SLC22A8—Methotrexate—muscle cancer	0.0508	0.055	CbGbCtD
Saxagliptin—CYP3A5—Vincristine—muscle cancer	0.04	0.0433	CbGbCtD
Saxagliptin—CYP3A5—Etoposide—muscle cancer	0.0367	0.0397	CbGbCtD
Saxagliptin—CYP3A4—Vincristine—muscle cancer	0.0156	0.0169	CbGbCtD
Saxagliptin—CYP3A4—Etoposide—muscle cancer	0.0143	0.0155	CbGbCtD
Saxagliptin—CYP3A4—Doxorubicin—muscle cancer	0.00975	0.0106	CbGbCtD
Saxagliptin—DPP8—smooth muscle tissue—muscle cancer	0.00503	0.0829	CbGeAlD
Saxagliptin—DPP8—cardiac atrium—muscle cancer	0.00434	0.0715	CbGeAlD
Saxagliptin—DPP9—tendon—muscle cancer	0.00415	0.0684	CbGeAlD
Saxagliptin—DPP8—tendon—muscle cancer	0.00378	0.0623	CbGeAlD
Saxagliptin—DPP8—bone marrow—muscle cancer	0.00366	0.0603	CbGeAlD
Saxagliptin—DPP8—vagina—muscle cancer	0.00351	0.0578	CbGeAlD
Saxagliptin—DPP9—testis—muscle cancer	0.00344	0.0567	CbGeAlD
Saxagliptin—DPP8—testis—muscle cancer	0.00313	0.0516	CbGeAlD
Saxagliptin—SLCO4C1—renal system—muscle cancer	0.00306	0.0505	CbGeAlD
Saxagliptin—DPP4—embryo—muscle cancer	0.00269	0.0443	CbGeAlD
Saxagliptin—SLCO4C1—bone marrow—muscle cancer	0.00232	0.0382	CbGeAlD
Saxagliptin—SLCO4C1—vagina—muscle cancer	0.00222	0.0366	CbGeAlD
Saxagliptin—DPP4—smooth muscle tissue—muscle cancer	0.00211	0.0348	CbGeAlD
Saxagliptin—DPP4—renal system—muscle cancer	0.00203	0.0335	CbGeAlD
Saxagliptin—DPP4—tendon—muscle cancer	0.00159	0.0262	CbGeAlD
Saxagliptin—DPP4—bone marrow—muscle cancer	0.00154	0.0253	CbGeAlD
Saxagliptin—DPP4—vagina—muscle cancer	0.00147	0.0243	CbGeAlD
Saxagliptin—DPP4—head—muscle cancer	0.00136	0.0224	CbGeAlD
Saxagliptin—SLC22A8—renal system—muscle cancer	0.00134	0.0221	CbGeAlD
Saxagliptin—Immunodeficiency—Methotrexate—muscle cancer	0.00132	0.0815	CcSEcCtD
Saxagliptin—DPP4—testis—muscle cancer	0.00131	0.0217	CbGeAlD
Saxagliptin—ABCC1—cardiac atrium—muscle cancer	0.00103	0.017	CbGeAlD
Saxagliptin—ABCC1—tendon—muscle cancer	0.000898	0.0148	CbGeAlD
Saxagliptin—SLC22A8—head—muscle cancer	0.000895	0.0148	CbGeAlD
Saxagliptin—CYP3A5—renal system—muscle cancer	0.000884	0.0146	CbGeAlD
Saxagliptin—ABCC1—vagina—muscle cancer	0.000833	0.0137	CbGeAlD
Saxagliptin—ABCC1—testis—muscle cancer	0.000743	0.0123	CbGeAlD
Saxagliptin—CYP3A4—renal system—muscle cancer	0.000663	0.0109	CbGeAlD
Saxagliptin—CYP3A5—vagina—muscle cancer	0.00064	0.0106	CbGeAlD
Saxagliptin—Opportunistic infection—Methotrexate—muscle cancer	0.000567	0.0351	CcSEcCtD
Saxagliptin—Opportunistic infection—Doxorubicin—muscle cancer	0.000491	0.0304	CcSEcCtD
Saxagliptin—Multiple fractures—Methotrexate—muscle cancer	0.000393	0.0243	CcSEcCtD
Saxagliptin—Fracture—Methotrexate—muscle cancer	0.000393	0.0243	CcSEcCtD
Saxagliptin—Lymphopenia—Doxorubicin—muscle cancer	0.000387	0.0239	CcSEcCtD
Saxagliptin—Erectile dysfunction—Vincristine—muscle cancer	0.000272	0.0168	CcSEcCtD
Saxagliptin—Infestation—Etoposide—muscle cancer	0.000213	0.0132	CcSEcCtD
Saxagliptin—Infestation NOS—Etoposide—muscle cancer	0.000213	0.0132	CcSEcCtD
Saxagliptin—Myalgia—Dactinomycin—muscle cancer	0.000196	0.0121	CcSEcCtD
Saxagliptin—Infection—Dactinomycin—muscle cancer	0.000187	0.0116	CcSEcCtD
Saxagliptin—Thrombocytopenia—Dactinomycin—muscle cancer	0.000184	0.0114	CcSEcCtD
Saxagliptin—Myalgia—Vincristine—muscle cancer	0.000175	0.0108	CcSEcCtD
Saxagliptin—Immune system disorder—Etoposide—muscle cancer	0.000173	0.0107	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000171	0.0106	CcSEcCtD
Saxagliptin—Anaphylactic shock—Vincristine—muscle cancer	0.000168	0.0104	CcSEcCtD
Saxagliptin—Infection—Vincristine—muscle cancer	0.000167	0.0103	CcSEcCtD
Saxagliptin—Thrombocytopenia—Vincristine—muscle cancer	0.000165	0.0102	CcSEcCtD
Saxagliptin—Fatigue—Dactinomycin—muscle cancer	0.000162	0.01	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000154	0.00952	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000153	0.00947	CcSEcCtD
Saxagliptin—Purpura—Doxorubicin—muscle cancer	0.000149	0.00922	CcSEcCtD
Saxagliptin—Abdominal pain—Dactinomycin—muscle cancer	0.000149	0.0092	CcSEcCtD
Saxagliptin—Hypoglycaemia—Doxorubicin—muscle cancer	0.000147	0.00911	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Vincristine—muscle cancer	0.000145	0.00898	CcSEcCtD
Saxagliptin—Fatigue—Vincristine—muscle cancer	0.000145	0.00896	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000141	0.00873	CcSEcCtD
Saxagliptin—Pancreatitis—Methotrexate—muscle cancer	0.000141	0.0087	CcSEcCtD
Saxagliptin—Face oedema—Doxorubicin—muscle cancer	0.000139	0.00858	CcSEcCtD
Saxagliptin—Hypersensitivity—Dactinomycin—muscle cancer	0.000139	0.00857	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Vincristine—muscle cancer	0.000137	0.0085	CcSEcCtD
Saxagliptin—Anaphylactic shock—Etoposide—muscle cancer	0.000136	0.00842	CcSEcCtD
Saxagliptin—Infection—Etoposide—muscle cancer	0.000135	0.00837	CcSEcCtD
Saxagliptin—Asthenia—Dactinomycin—muscle cancer	0.000135	0.00835	CcSEcCtD
Saxagliptin—Blood creatinine increased—Doxorubicin—muscle cancer	0.000135	0.00833	CcSEcCtD
Saxagliptin—Thrombocytopenia—Etoposide—muscle cancer	0.000133	0.00825	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000133	0.00825	CcSEcCtD
Saxagliptin—Abdominal pain—Vincristine—muscle cancer	0.000133	0.00822	CcSEcCtD
Saxagliptin—Skin disorder—Etoposide—muscle cancer	0.000132	0.00818	CcSEcCtD
Saxagliptin—Erectile dysfunction—Methotrexate—muscle cancer	0.000132	0.00817	CcSEcCtD
Saxagliptin—Nasopharyngitis—Doxorubicin—muscle cancer	0.000128	0.00795	CcSEcCtD
Saxagliptin—Infestation—Methotrexate—muscle cancer	0.000128	0.00791	CcSEcCtD
Saxagliptin—Infestation NOS—Methotrexate—muscle cancer	0.000128	0.00791	CcSEcCtD
Saxagliptin—Gastritis—Doxorubicin—muscle cancer	0.000127	0.00787	CcSEcCtD
Saxagliptin—Hypersensitivity—Vincristine—muscle cancer	0.000124	0.00766	CcSEcCtD
Saxagliptin—Pancreatitis—Doxorubicin—muscle cancer	0.000122	0.00753	CcSEcCtD
Saxagliptin—Asthenia—Vincristine—muscle cancer	0.000121	0.00746	CcSEcCtD
Saxagliptin—Vomiting—Dactinomycin—muscle cancer	0.00012	0.0074	CcSEcCtD
Saxagliptin—Rash—Dactinomycin—muscle cancer	0.000119	0.00734	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Etoposide—muscle cancer	0.000118	0.00727	CcSEcCtD
Saxagliptin—Fatigue—Etoposide—muscle cancer	0.000117	0.00726	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000115	0.00714	CcSEcCtD
Saxagliptin—Nausea—Dactinomycin—muscle cancer	0.000112	0.00691	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Etoposide—muscle cancer	0.000111	0.00689	CcSEcCtD
Saxagliptin—Dizziness—Vincristine—muscle cancer	0.000111	0.00688	CcSEcCtD
Saxagliptin—Infestation NOS—Doxorubicin—muscle cancer	0.000111	0.00685	CcSEcCtD
Saxagliptin—Infestation—Doxorubicin—muscle cancer	0.000111	0.00685	CcSEcCtD
Saxagliptin—Urticaria—Etoposide—muscle cancer	0.000108	0.00669	CcSEcCtD
Saxagliptin—Abdominal pain—Etoposide—muscle cancer	0.000108	0.00666	CcSEcCtD
Saxagliptin—Urinary tract infection—Doxorubicin—muscle cancer	0.000108	0.00666	CcSEcCtD
Saxagliptin—Vomiting—Vincristine—muscle cancer	0.000107	0.00661	CcSEcCtD
Saxagliptin—Rash—Vincristine—muscle cancer	0.000106	0.00656	CcSEcCtD
Saxagliptin—Dermatitis—Vincristine—muscle cancer	0.000106	0.00655	CcSEcCtD
Saxagliptin—Headache—Vincristine—muscle cancer	0.000105	0.00651	CcSEcCtD
Saxagliptin—Sinusitis—Doxorubicin—muscle cancer	0.000104	0.00643	CcSEcCtD
Saxagliptin—Immune system disorder—Methotrexate—muscle cancer	0.000104	0.00641	CcSEcCtD
Saxagliptin—Hypersensitivity—Etoposide—muscle cancer	0.0001	0.00621	CcSEcCtD
Saxagliptin—Malnutrition—Methotrexate—muscle cancer	9.99e-05	0.00618	CcSEcCtD
Saxagliptin—Nausea—Vincristine—muscle cancer	9.98e-05	0.00618	CcSEcCtD
Saxagliptin—Oedema peripheral—Doxorubicin—muscle cancer	9.79e-05	0.00606	CcSEcCtD
Saxagliptin—Asthenia—Etoposide—muscle cancer	9.77e-05	0.00604	CcSEcCtD
Saxagliptin—Pruritus—Etoposide—muscle cancer	9.63e-05	0.00596	CcSEcCtD
Saxagliptin—Dizziness—Etoposide—muscle cancer	9e-05	0.00557	CcSEcCtD
Saxagliptin—Immune system disorder—Doxorubicin—muscle cancer	8.98e-05	0.00555	CcSEcCtD
Saxagliptin—Vomiting—Etoposide—muscle cancer	8.66e-05	0.00536	CcSEcCtD
Saxagliptin—Malnutrition—Doxorubicin—muscle cancer	8.65e-05	0.00535	CcSEcCtD
Saxagliptin—Rash—Etoposide—muscle cancer	8.58e-05	0.00531	CcSEcCtD
Saxagliptin—Dermatitis—Etoposide—muscle cancer	8.58e-05	0.00531	CcSEcCtD
Saxagliptin—Headache—Etoposide—muscle cancer	8.53e-05	0.00528	CcSEcCtD
Saxagliptin—Flatulence—Doxorubicin—muscle cancer	8.52e-05	0.00527	CcSEcCtD
Saxagliptin—Arthralgia—Methotrexate—muscle cancer	8.51e-05	0.00526	CcSEcCtD
Saxagliptin—Myalgia—Methotrexate—muscle cancer	8.51e-05	0.00526	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	8.45e-05	0.00523	CcSEcCtD
Saxagliptin—Anaphylactic shock—Methotrexate—muscle cancer	8.15e-05	0.00505	CcSEcCtD
Saxagliptin—Infection—Methotrexate—muscle cancer	8.1e-05	0.00501	CcSEcCtD
Saxagliptin—Nausea—Etoposide—muscle cancer	8.09e-05	0.005	CcSEcCtD
Saxagliptin—Thrombocytopenia—Methotrexate—muscle cancer	7.98e-05	0.00494	CcSEcCtD
Saxagliptin—Skin disorder—Methotrexate—muscle cancer	7.92e-05	0.0049	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Methotrexate—muscle cancer	7.43e-05	0.0046	CcSEcCtD
Saxagliptin—Myalgia—Doxorubicin—muscle cancer	7.37e-05	0.00456	CcSEcCtD
Saxagliptin—Arthralgia—Doxorubicin—muscle cancer	7.37e-05	0.00456	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	7.31e-05	0.00453	CcSEcCtD
Saxagliptin—Dyspepsia—Methotrexate—muscle cancer	7.18e-05	0.00444	CcSEcCtD
Saxagliptin—Anaphylactic shock—Doxorubicin—muscle cancer	7.06e-05	0.00437	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Methotrexate—muscle cancer	7.04e-05	0.00436	CcSEcCtD
Saxagliptin—Fatigue—Methotrexate—muscle cancer	7.03e-05	0.00435	CcSEcCtD
Saxagliptin—Infection—Doxorubicin—muscle cancer	7.01e-05	0.00434	CcSEcCtD
Saxagliptin—Thrombocytopenia—Doxorubicin—muscle cancer	6.91e-05	0.00428	CcSEcCtD
Saxagliptin—Skin disorder—Doxorubicin—muscle cancer	6.86e-05	0.00424	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Methotrexate—muscle cancer	6.67e-05	0.00413	CcSEcCtD
Saxagliptin—Urticaria—Methotrexate—muscle cancer	6.48e-05	0.00401	CcSEcCtD
Saxagliptin—Abdominal pain—Methotrexate—muscle cancer	6.45e-05	0.00399	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	6.43e-05	0.00398	CcSEcCtD
Saxagliptin—Dyspepsia—Doxorubicin—muscle cancer	6.21e-05	0.00385	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Doxorubicin—muscle cancer	6.1e-05	0.00377	CcSEcCtD
Saxagliptin—Fatigue—Doxorubicin—muscle cancer	6.09e-05	0.00377	CcSEcCtD
Saxagliptin—Hypersensitivity—Methotrexate—muscle cancer	6.01e-05	0.00372	CcSEcCtD
Saxagliptin—Asthenia—Methotrexate—muscle cancer	5.85e-05	0.00362	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Doxorubicin—muscle cancer	5.77e-05	0.00357	CcSEcCtD
Saxagliptin—Pruritus—Methotrexate—muscle cancer	5.77e-05	0.00357	CcSEcCtD
Saxagliptin—Urticaria—Doxorubicin—muscle cancer	5.61e-05	0.00347	CcSEcCtD
Saxagliptin—Abdominal pain—Doxorubicin—muscle cancer	5.58e-05	0.00345	CcSEcCtD
Saxagliptin—Dizziness—Methotrexate—muscle cancer	5.39e-05	0.00334	CcSEcCtD
Saxagliptin—Hypersensitivity—Doxorubicin—muscle cancer	5.2e-05	0.00322	CcSEcCtD
Saxagliptin—Vomiting—Methotrexate—muscle cancer	5.18e-05	0.00321	CcSEcCtD
Saxagliptin—Rash—Methotrexate—muscle cancer	5.14e-05	0.00318	CcSEcCtD
Saxagliptin—Dermatitis—Methotrexate—muscle cancer	5.14e-05	0.00318	CcSEcCtD
Saxagliptin—Headache—Methotrexate—muscle cancer	5.11e-05	0.00316	CcSEcCtD
Saxagliptin—Asthenia—Doxorubicin—muscle cancer	5.07e-05	0.00313	CcSEcCtD
Saxagliptin—Pruritus—Doxorubicin—muscle cancer	5e-05	0.00309	CcSEcCtD
Saxagliptin—Nausea—Methotrexate—muscle cancer	4.84e-05	0.003	CcSEcCtD
Saxagliptin—Dizziness—Doxorubicin—muscle cancer	4.67e-05	0.00289	CcSEcCtD
Saxagliptin—Vomiting—Doxorubicin—muscle cancer	4.49e-05	0.00278	CcSEcCtD
Saxagliptin—Rash—Doxorubicin—muscle cancer	4.45e-05	0.00275	CcSEcCtD
Saxagliptin—Dermatitis—Doxorubicin—muscle cancer	4.45e-05	0.00275	CcSEcCtD
Saxagliptin—Headache—Doxorubicin—muscle cancer	4.42e-05	0.00274	CcSEcCtD
Saxagliptin—Nausea—Doxorubicin—muscle cancer	4.19e-05	0.00259	CcSEcCtD
